Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back

Summary After over a century of preclinical and clinical development, a number of artificial oxygen carriers based either on perfluorochemicals or hemoglobins are currently in advanced clinical trials for their ability to replace red blood cells and to ensure adequate tissue oxygenation in case of a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer treatment reviews 2007-12, Vol.33 (8), p.757-761
Hauptverfasser: Yu, Minghua, Dai, Min, Liu, Qian, Xiu, Ruijuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 761
container_issue 8
container_start_page 757
container_title Cancer treatment reviews
container_volume 33
creator Yu, Minghua
Dai, Min
Liu, Qian
Xiu, Ruijuan
description Summary After over a century of preclinical and clinical development, a number of artificial oxygen carriers based either on perfluorochemicals or hemoglobins are currently in advanced clinical trials for their ability to replace red blood cells and to ensure adequate tissue oxygenation in case of acute anemia or infarction. On the other hand, intravenous administration of perflourocarbone emulsions or hemoglobin solutions were effective in increasing the oxygenation throughout experimental tumors, and fueled by exciting new developments in the field, some products are experimentally and clinically investigated as cancer chemo- and radiosensitizing agents. This review is to provide a first overview of the current status of artificial oxygen carriers as a oxygen therapeutics in cancer chemo- and radiotherapy sensitization.
doi_str_mv 10.1016/j.ctrv.2007.08.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68528667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030573720700117X</els_id><sourcerecordid>68528667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-8c930a8e0d4b673a77f97cbd7622cf3568797e58a7672e3180b8258d8cd699f83</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYModl39Aj7IPPk2403SSTIigi22CoU-qCD4EDLJHTfb2WRNZku3n95Md0HwoU_3D-ccuL9LyGsKDQUq3q0bO6XbhgHIBlQDwJ6QBW05q2kn5FOyAA5tLblkJ-RFzmsA6LjonpMTKkvTglyQX9d3-98YKmtS8phyZYIrQ7CYKrvCTawfNsk4H6cVJrPdVxlD9pO_N5OP4X11hsGuqilWPbrsHT4YemNvXpJngxkzvjrWJflx8fn7-Zf66vry6_mnq9qeynaqle04GIXgTnshuZFy6KTtnRSM2YG3QslOYquMFJIhpwp6xVrllHWi6wbFl-TtIXeb4p8d5klvfLY4jiZg3GUtVMuUKNFLwg5Cm2LOCQe9TX5j0l5T0DNSvdYzUj0j1aB0QVpMb47pu36D7p_lyLAIPhwEWG68LRB1tr4wQecT2km76B_P__if3Y4-eGvGG9xjXsddCoWepjozDfrb_NT5pyABKJU_-V_xiJyF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68528667</pqid></control><display><type>article</type><title>Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Yu, Minghua ; Dai, Min ; Liu, Qian ; Xiu, Ruijuan</creator><creatorcontrib>Yu, Minghua ; Dai, Min ; Liu, Qian ; Xiu, Ruijuan</creatorcontrib><description>Summary After over a century of preclinical and clinical development, a number of artificial oxygen carriers based either on perfluorochemicals or hemoglobins are currently in advanced clinical trials for their ability to replace red blood cells and to ensure adequate tissue oxygenation in case of acute anemia or infarction. On the other hand, intravenous administration of perflourocarbone emulsions or hemoglobin solutions were effective in increasing the oxygenation throughout experimental tumors, and fueled by exciting new developments in the field, some products are experimentally and clinically investigated as cancer chemo- and radiosensitizing agents. This review is to provide a first overview of the current status of artificial oxygen carriers as a oxygen therapeutics in cancer chemo- and radiotherapy sensitization.</description><identifier>ISSN: 0305-7372</identifier><identifier>EISSN: 1532-1967</identifier><identifier>DOI: 10.1016/j.ctrv.2007.08.002</identifier><identifier>PMID: 17936507</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Blood Substitutes - pharmacology ; Cancer therapy ; Cell Hypoxia - drug effects ; Clinical Trials as Topic ; Drug resistance ; Hematology, Oncology and Palliative Medicine ; Humans ; Hypoxia ; Neoplasms - drug therapy ; Neoplasms - radiotherapy ; Oxygen carriers ; Radiation sensitizing agents ; Radiation-Sensitizing Agents - pharmacology</subject><ispartof>Cancer treatment reviews, 2007-12, Vol.33 (8), p.757-761</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-8c930a8e0d4b673a77f97cbd7622cf3568797e58a7672e3180b8258d8cd699f83</citedby><cites>FETCH-LOGICAL-c475t-8c930a8e0d4b673a77f97cbd7622cf3568797e58a7672e3180b8258d8cd699f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ctrv.2007.08.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17936507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Minghua</creatorcontrib><creatorcontrib>Dai, Min</creatorcontrib><creatorcontrib>Liu, Qian</creatorcontrib><creatorcontrib>Xiu, Ruijuan</creatorcontrib><title>Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back</title><title>Cancer treatment reviews</title><addtitle>Cancer Treat Rev</addtitle><description>Summary After over a century of preclinical and clinical development, a number of artificial oxygen carriers based either on perfluorochemicals or hemoglobins are currently in advanced clinical trials for their ability to replace red blood cells and to ensure adequate tissue oxygenation in case of acute anemia or infarction. On the other hand, intravenous administration of perflourocarbone emulsions or hemoglobin solutions were effective in increasing the oxygenation throughout experimental tumors, and fueled by exciting new developments in the field, some products are experimentally and clinically investigated as cancer chemo- and radiosensitizing agents. This review is to provide a first overview of the current status of artificial oxygen carriers as a oxygen therapeutics in cancer chemo- and radiotherapy sensitization.</description><subject>Animals</subject><subject>Blood Substitutes - pharmacology</subject><subject>Cancer therapy</subject><subject>Cell Hypoxia - drug effects</subject><subject>Clinical Trials as Topic</subject><subject>Drug resistance</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - radiotherapy</subject><subject>Oxygen carriers</subject><subject>Radiation sensitizing agents</subject><subject>Radiation-Sensitizing Agents - pharmacology</subject><issn>0305-7372</issn><issn>1532-1967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9rFDEUxYModl39Aj7IPPk2403SSTIigi22CoU-qCD4EDLJHTfb2WRNZku3n95Md0HwoU_3D-ccuL9LyGsKDQUq3q0bO6XbhgHIBlQDwJ6QBW05q2kn5FOyAA5tLblkJ-RFzmsA6LjonpMTKkvTglyQX9d3-98YKmtS8phyZYIrQ7CYKrvCTawfNsk4H6cVJrPdVxlD9pO_N5OP4X11hsGuqilWPbrsHT4YemNvXpJngxkzvjrWJflx8fn7-Zf66vry6_mnq9qeynaqle04GIXgTnshuZFy6KTtnRSM2YG3QslOYquMFJIhpwp6xVrllHWi6wbFl-TtIXeb4p8d5klvfLY4jiZg3GUtVMuUKNFLwg5Cm2LOCQe9TX5j0l5T0DNSvdYzUj0j1aB0QVpMb47pu36D7p_lyLAIPhwEWG68LRB1tr4wQecT2km76B_P__if3Y4-eGvGG9xjXsddCoWepjozDfrb_NT5pyABKJU_-V_xiJyF</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Yu, Minghua</creator><creator>Dai, Min</creator><creator>Liu, Qian</creator><creator>Xiu, Ruijuan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071201</creationdate><title>Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back</title><author>Yu, Minghua ; Dai, Min ; Liu, Qian ; Xiu, Ruijuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-8c930a8e0d4b673a77f97cbd7622cf3568797e58a7672e3180b8258d8cd699f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Blood Substitutes - pharmacology</topic><topic>Cancer therapy</topic><topic>Cell Hypoxia - drug effects</topic><topic>Clinical Trials as Topic</topic><topic>Drug resistance</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - radiotherapy</topic><topic>Oxygen carriers</topic><topic>Radiation sensitizing agents</topic><topic>Radiation-Sensitizing Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Minghua</creatorcontrib><creatorcontrib>Dai, Min</creatorcontrib><creatorcontrib>Liu, Qian</creatorcontrib><creatorcontrib>Xiu, Ruijuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer treatment reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Minghua</au><au>Dai, Min</au><au>Liu, Qian</au><au>Xiu, Ruijuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back</atitle><jtitle>Cancer treatment reviews</jtitle><addtitle>Cancer Treat Rev</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>33</volume><issue>8</issue><spage>757</spage><epage>761</epage><pages>757-761</pages><issn>0305-7372</issn><eissn>1532-1967</eissn><abstract>Summary After over a century of preclinical and clinical development, a number of artificial oxygen carriers based either on perfluorochemicals or hemoglobins are currently in advanced clinical trials for their ability to replace red blood cells and to ensure adequate tissue oxygenation in case of acute anemia or infarction. On the other hand, intravenous administration of perflourocarbone emulsions or hemoglobin solutions were effective in increasing the oxygenation throughout experimental tumors, and fueled by exciting new developments in the field, some products are experimentally and clinically investigated as cancer chemo- and radiosensitizing agents. This review is to provide a first overview of the current status of artificial oxygen carriers as a oxygen therapeutics in cancer chemo- and radiotherapy sensitization.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>17936507</pmid><doi>10.1016/j.ctrv.2007.08.002</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7372
ispartof Cancer treatment reviews, 2007-12, Vol.33 (8), p.757-761
issn 0305-7372
1532-1967
language eng
recordid cdi_proquest_miscellaneous_68528667
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Animals
Blood Substitutes - pharmacology
Cancer therapy
Cell Hypoxia - drug effects
Clinical Trials as Topic
Drug resistance
Hematology, Oncology and Palliative Medicine
Humans
Hypoxia
Neoplasms - drug therapy
Neoplasms - radiotherapy
Oxygen carriers
Radiation sensitizing agents
Radiation-Sensitizing Agents - pharmacology
title Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T04%3A32%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxygen%20carriers%20and%20cancer%20chemo-%20and%20radiotherapy%20sensitization:%20Bench%20to%20bedside%20and%20back&rft.jtitle=Cancer%20treatment%20reviews&rft.au=Yu,%20Minghua&rft.date=2007-12-01&rft.volume=33&rft.issue=8&rft.spage=757&rft.epage=761&rft.pages=757-761&rft.issn=0305-7372&rft.eissn=1532-1967&rft_id=info:doi/10.1016/j.ctrv.2007.08.002&rft_dat=%3Cproquest_cross%3E68528667%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68528667&rft_id=info:pmid/17936507&rft_els_id=S030573720700117X&rfr_iscdi=true